A-90289 A and B, new inhibitors of bacterial translocase I, produced by Streptomyces sp. SANK 60405

Journal of Antibiotics

Volumn 64, Issue 7, 2011, Pages 495-501

  Fujita, Yoko ^a   Kizuka, Masaaki ^a   Funabashi, Masanori ^a   Ogawa, Yasumasa ^a   Ishikawa, Tomio ^a   Nonaka, Koichi ^a   Takatsu, Toshio ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

FAB CID; NMR; nucleoside antibiotics; sulfate; sulfotransferase; translocase I

Indexed keywords

A 90289 A; A 90289 B; ANTIBIOTIC AGENT; BACTERIAL DNA; BACTERIAL ENZYME; CARRIER PROTEIN; DNA 16S; ENZYME INHIBITOR; GENOMIC DNA; MURAMINOMICIN F; SULFATE; TRANSLOCASE I; UNCLASSIFIED DRUG; URIDINE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; ENZYME INHIBITION; FRAGMENTATION REACTION; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR SINGLE QUANTUM COHERENCE; IC 50; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; STREPTOMYCES;

ANTI-BACTERIAL AGENTS; AZEPINES; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; STREPTOMYCES; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS); URACIL;

BACTERIA (MICROORGANISMS); STREPTOMYCES SP.;

EID: 79960966685     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2011.38     Document Type: Article

References (27)

1. Kimura, K. & Bugg, T. D. H. Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis. Nat. Prod. Rep. 20, 252-273 (2003). (Pubitemid 36453610)
2. Inukai, M. et al. Mureidomycin A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. I. Taxonomy, fermentation, isolation and physicochemical properties. J. Antibiot. 42, 662-666 (1989). (Pubitemid 19142316)
3. Karwowski, J. P. et al. Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. I. Taxonomy of the producing organism and fermentation. J. Antibiot. 42, 506-511 (1989). (Pubitemid 19119086)
4. Chatterjee, S. et al. Napsamycins, new Pseudomonas active antibiotics of mureidomycin family from Streptomyces sp. HIL Y-82, 11372. J. Antibiot. 47, 595-598 (1994). (Pubitemid 24166635)
5. Ubukata, M. & Isono, K. The structure of liposidomycin B, an inhibitor of bacterial peptidoglycan synthesis. J. Am. Chem. Soc. 110, 4416-4417 (1988).
6. Ubukata, M. et al. Structure elucidation of liposidomycins, a class of complex lipid nucleoside antibiotics. J. Org. Chem. 57, 6392-6403 (1992). (Pubitemid 23017298)
7. Takatsuki, A., Arima, K. & Tamura, G. Tunicamycin, a new antibiotic. I. Isolation and characterization of tunicamycin. J. Antibiot. 24, 215-223 (1971).
8. Yamaguchi, H. et al. Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization. J. Antibiot. 39, 1047-1053 (1986). (Pubitemid 16046363)
9. Seto, H. et al. The structure of a new nucleoside antibiotic, capuramycin. Tetrahedron Lett. 29, 2343-2346 (1988).
10. McDonald, L. A. et al. Structures of the muraymycins, novel peptidoglycan biosynthesis inhibitors. J. Am. Chem. Soc. 124, 10260-10261 (2002). (Pubitemid 34977365)
11. Igarashi, M. et al. Caprazamycn B, a novel anti-tuberculosis antibiotic, from Streptomyces sp. J. Antibiot. 56, 580-583 (2003). (Pubitemid 36849946)
12. Igarashi, M. et al. Caprazamycns, novel lipo-nucleoside antibiotics, from Streptomyces sp. II. Structure elucidation of caprazamycins. J. Antibiot. 58, 327-337 (2005). (Pubitemid 40874451)
13. Murakami, R. et al. A-102395, a new inhibitor of bacterial translocase I, produced by Amycolatopsis sp. SANK 60206. J. Antibiot. 60, 690-695 (2007).
14. Murakami, R. et al. A-94964, novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. I. Taxonomy, fermentation, isolation and biological activity. J. Antibiot. 61, 537-544 (2008).
15. Fujita, Y., Murakami, R., Muramatsu, Y., Miyakoshi, S. & Takatsu, T. A-94964, novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. II. Physico-chemical properties and structure elucidation. J. Antibiot. 61, 545-549 (2008).
16. Muramatsu, Y. et al. New antibiotic muraminomicin. Jpn. Kokai Tokkyo Koho 2004-196780, 15 July (2004).
17. Fujita, Y., Kizuka, M. & Murakami, R. New compound A-97065. Jpn. Kokai Tokkyo Koho 2008-074710, 3 April (2008).
18. Crow, F. W., Tomer, K. B., Gross, M. L., McCloskey, J. A. & Bergstrom, D. E. Fast atom bombardment combined with tandem mass spectrometry for the determination of nucleosides. Anal. Biochem. 139, 243-262 (1984). (Pubitemid 14082119)
19. Isono, K. et al. Liposidomycins: novel nucleoside antibiotics which inhibit bacterial peptidoglycan synthesis. J. Antibiot. 38, 1617-1621 (1985). (Pubitemid 16217854)
20. Kimura, K. et al. New types of liposidomycins that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. II Isolation and structure elucidation. J. Antibiot. 51, 647-654 (1998). (Pubitemid 28398755)
21. Funabashi, M. et al. The biosynthesis of liposidomycin-like A-90289 antibiotics featuring a new type of sulfotransferase. Chembiochem 11, 184-190 (2010).
22. Iwamoto, T. et al. WF11899A, B and C, novel antifungal lipopeptides I. Taxonomy, fermentation, isolation and physico-chemical properties. J. Antibiot. 47, 1084-1091 (1994). (Pubitemid 24351556)
23. Hasegawa, T., Takizawa, M. & Tanida, S. A rapid analysis for chemical grouping of aerobic actinomycetes. J. Gen. Appl. Microbiol. 29, 319-322 (1983). (Pubitemid 14176930)
24. Nakagawa, Y. & Kawasaki, H. Identification Manual of Actinomycetes. (eds The Society for Actinomycetes. Japan) 83-117 (Business Center for Academic Societies Japan, Tokyo, 2001).
25. Saitou, N. & Nei, M. The neighbor-joining method: a new method of constructing phylogenetic tree. Mol. Biol. Evol. 6, 514-525 (1987).
26. Tamura, K., Dudley, J., Nei, M. & Kumar, S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0. Mol. Biol. Evol. 24, 1596-1599 (2007). (Pubitemid 47236692)
27. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobialsusceptibility test for bacteria that grow aerobically; approved standard, 7th ed. CLSI document M7-A7 (Clinical and Laboratory Standard Institute, Wayne, PA, 2006).